There was some intriguing news from a Pfizer (NYSE: PFE) shareholder on Thursday that was not taken well by the market.
Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...
US Treasuries and stock futures endured a bout of volatility as investors weighed economic data releases showing a smaller than expected decline in inflation and the highest level of jobless claims in ...
US stocks declined on Thursday, with the S&P 500 and Dow Jones Industrial Average retreating from record highs amid signs of ...
Wall Street's main indices closed lower on Thursday as investors looked to higher-than-expected inflation and unemployment ...
Both the S&P 500 and the Dow had notched record closing highs in the previous day’s session. Read more at straitstimes.com.
Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current CEO ...
On Thursday, Starboard Value LP, a significant shareholder of Pfizer Inc. (NYSE:PFE), issued a letter to the company’s Board ...
Pfizer (PFE) stock slips as former executives Ian Read and Frank D'Amelio exit Starboard Value's activist campaign against ...
Shares of Pfizer Inc. PFE shed 2.82% to $29.34 Thursday, on what proved to be an all-around grim trading session for the ...
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...